Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Booms, Busts, and Recoveries -- Ignore unavailable to you. Want to Upgrade?

To: Louis V. Lambrecht who wrote (37318)	8/19/2003 11:31:20 AM
From: re3	Respond to of 74559

mmm, i think HMY fell under 10 bucks last summer by a couple of pennies...so your study needs more work !

To: Louis V. Lambrecht who wrote (37318)	8/19/2003 11:51:05 AM
From: Tadsamillionaire	Read Replies (1) \| Respond to of 74559

FDA to Forest: Stop Selling Thyroid Drug Tuesday August 19, 10:23 am ET WASHINGTON (Reuters) - The U.S. Food and Drug Administration (News - Websites) has sent a warning to Forest Laboratories Inc. (NYSE:FRX - News) for failing to obtain approval for thyroid drug Levothroid and told the company to stop marketing it, according to a letter released on Tuesday. "You have failed to obtain an approved application and have made a deliberate decision not to follow the agency's gradual phase-out plan ...," the FDA wrote in a letter dated Aug. 7. The letter was posted on the agency's Web site on Tuesday. Thyroid drugs containing levothyroxine sodium were sold for years without FDA approval. In July 2001, the FDA told companies selling the drugs to submit applications for approval by August 14, 2003, while gradually phasing out production over two years. Because Forest failed to do so, the FDA told the company to stop selling Levothroid. The letter requests a response within 15 days "stating the action you will take to discontinue the marketing of your Levothroid drug products." A Forest spokesman could not immediately be reached for comment. Forest shares fell 10 cents to $43.04 in morning trading on the New York Stock Exchange (News - Websites). biz.yahoo.com